AT348981B - Verfahren zur herstellung neuer 5-sulfonamido- 2-amino-benzoesaeurederivate sowie ihrer saeureadditonssalze - Google Patents

Verfahren zur herstellung neuer 5-sulfonamido- 2-amino-benzoesaeurederivate sowie ihrer saeureadditonssalze

Info

Publication number
AT348981B
AT348981B AT180277A AT180277A AT348981B AT 348981 B AT348981 B AT 348981B AT 180277 A AT180277 A AT 180277A AT 180277 A AT180277 A AT 180277A AT 348981 B AT348981 B AT 348981B
Authority
AT
Austria
Prior art keywords
sulfonamido
amino
new
production
benzoic acid
Prior art date
Application number
AT180277A
Other languages
English (en)
Other versions
ATA180277A (de
Inventor
Judit Dr Kosary
Endre Dr Kasztreiner
Zsuzsa Dr Huszti
Agnes Kenessey
Gyoergy Dr Cseh
Veronika Szilagyi
Judit Stverteczky
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU76GO00001334A external-priority patent/HU172949B/hu
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ATA180277A publication Critical patent/ATA180277A/de
Application granted granted Critical
Publication of AT348981B publication Critical patent/AT348981B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT180277A 1976-03-18 1977-03-16 Verfahren zur herstellung neuer 5-sulfonamido- 2-amino-benzoesaeurederivate sowie ihrer saeureadditonssalze AT348981B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU76GO00001334A HU172949B (hu) 1976-03-18 1976-03-18 Sposob poluchenija novykh proizvodnykh sul'fonamido-benzojnoj kisloty
DE19762611705 DE2611705A1 (de) 1976-03-18 1976-03-18 N-5-(nitrofurfuryliden-)-1-amino- hydantoin enthaltende kristalloesungsmittel

Publications (2)

Publication Number Publication Date
ATA180277A ATA180277A (de) 1978-08-15
AT348981B true AT348981B (de) 1979-03-12

Family

ID=25770228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT180277A AT348981B (de) 1976-03-18 1977-03-16 Verfahren zur herstellung neuer 5-sulfonamido- 2-amino-benzoesaeurederivate sowie ihrer saeureadditonssalze

Country Status (9)

Country Link
US (1) US4244871A (de)
JP (1) JPS52136146A (de)
AT (1) AT348981B (de)
CA (1) CA1092111A (de)
DE (2) DE2611705A1 (de)
FR (1) FR2344531A1 (de)
GB (1) GB1561243A (de)
NL (1) NL7702991A (de)
SE (1) SE7703068L (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58192820A (ja) * 1982-05-06 1983-11-10 Mochida Pharmaceut Co Ltd 抗ウイルス作用を有する医薬組成物
IT1176613B (it) * 1984-08-14 1987-08-18 Ravizza Spa Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
JPS61134382A (ja) * 1984-12-04 1986-06-21 Kyorin Pharmaceut Co Ltd 新規なスルファモイル安息香酸誘導体およびその製造法
CA2328413A1 (en) 1998-04-20 1999-10-28 Fujisawa Pharmaceutical Co., Ltd. Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
SI1703909T1 (sl) * 2003-09-09 2009-08-31 Hoffmann La Roche Derivati 1-benzoil-piperazina kot inhibitorji vnosa glicina za zdravljenje psihoz
ES2294529T3 (es) * 2003-09-09 2008-04-01 F. Hoffmann-La Roche Ag Derivados de 1-(2-amino-benzoil)-piperacina como inhibidores de absorcion de glicina para el tratamiento de psicosis.
SI1828154T1 (sl) * 2004-12-09 2009-08-31 Hoffmann La Roche Derivati fenil-piperazin metanona
ATE457989T1 (de) * 2004-12-15 2010-03-15 Hoffmann La Roche Bi- und trizyklische substituierte phenyl- methanone als inhibitoren von glycin-i (glyt-1)- transportern zur behandlung der alzheimer- krankheit
US7485637B2 (en) * 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
WO2006072435A1 (en) * 2005-01-06 2006-07-13 F.Hoffmann-La Roche Ag Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
JP5006799B2 (ja) * 2005-01-07 2012-08-22 エフ．ホフマン−ラ ロシュ アーゲー 神経疾患及び精神神経疾患の処置用のグリシントランスポーター１（ｇｌｙｔ−１）阻害剤としての［４−（ヘテロアリール）ピペラジン−１−イル］−（２，５−置換フェニル）−メタノン誘導体
DE602006007682D1 (de) * 2005-01-18 2009-08-20 Hoffmann La Roche 2,5-disubstituierte phenylmethanonderivative als glycintransporter-1-inhibitoren (glyt-1) zur behandlung von neurologischen und neuropsychiatrischen störungen
CA2595605A1 (en) * 2005-01-26 2006-08-03 F. Hoffmann-La Roche Ag Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
NZ556434A (en) * 2005-02-07 2010-05-28 Hoffmann La Roche Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
GB0505086D0 (en) * 2005-03-11 2005-04-20 Glaxo Group Ltd Compounds
CN102395270B (zh) * 2008-07-07 2014-11-12 法斯根公司 化合物、含有其的药物组合物、其使用方法及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2910488A (en) * 1958-01-22 1959-10-27 Merck & Co Inc Aniline derivatives
US3346568A (en) * 1961-09-14 1967-10-10 Ciba Geigy Corp 2-amino-5-sulfamyl-benzoic acid hydrazides
FR1403935A (fr) * 1963-06-05 1965-06-25 Ciba Geigy Nouveaux amides d'acides anthraniliques
US3839321A (en) * 1966-07-21 1974-10-01 Smithkline Corp 5-sulfamoyl-n-(2-substituted-ethyl) anthranilic acids
US3522274A (en) * 1967-05-24 1970-07-28 American Home Prod 2,3-dihydro-1-alkyl-7-sulfamoyl-4,1-benzoxazepin-5(1h)-ones
US3843662A (en) * 1971-12-09 1974-10-22 Pfizer 2-halo-5-(substituted piperidino sulfonyl)benzoic acids
DE2232457A1 (de) * 1972-07-01 1974-01-10 Boehringer Mannheim Gmbh Neue 3-alkyl-4-sulfamoylanilinderivate
DE2423847A1 (de) * 1973-05-28 1975-01-02 Ciba Geigy Ag Neue sulfamoylbenzoesaeureamide
CH590261A5 (de) * 1973-07-10 1977-07-29 Ciba Geigy Ag

Also Published As

Publication number Publication date
US4244871A (en) 1981-01-13
ATA180277A (de) 1978-08-15
JPS52136146A (en) 1977-11-14
GB1561243A (en) 1980-02-13
DE2611705A1 (de) 1977-09-22
DE2712023A1 (de) 1977-10-06
FR2344531A1 (fr) 1977-10-14
NL7702991A (nl) 1977-09-20
FR2344531B1 (de) 1980-04-04
CA1092111A (en) 1980-12-23
SE7703068L (sv) 1977-09-19

Similar Documents

Publication Publication Date Title
ATA630875A (de) Verfahren zur herstellung neuer derivate der 3-chinolincarbonsaure sowie ihrer saureadditionssalze
AT367418B (de) Verfahren zur herstellung neuer tetrahydropyridinylindolderivate und ihrer salze
ATA922877A (de) Verfahren zur herstellung von neuen ver- aetherten cyclopentan-1-aminen sowie deren salzen
AT294108B (de) Verfahren zur Herstellung neuer Benzamidoäthylpiperazine sowie ihrer Säureadditionssalze
AT348981B (de) Verfahren zur herstellung neuer 5-sulfonamido- 2-amino-benzoesaeurederivate sowie ihrer saeureadditonssalze
AT366682B (de) Verfahren zur herstellung neuer 3-fluor-6piperazinylmorphanthridine und ihrer saeureadditionssalze
AT363474B (de) Verfahren zur herstellung neuer carbostyrilderivate und ihrer pharmazeutisch geeigneten saeureadditionssalze
AT350737B (de) Verfahren zur herstellung neuer n-tetrahydro- furfuryl-noroxymorphone und deren saeure- additionssalzen
AT370421B (de) Verfahren zur herstellung von alkaloiden des leurosin-typs sowie von deren salzen
AT347451B (de) Verfahren zur herstellung neuer 2-acetylamino- thiazolderivate sowie ihrer saeureadditions- salze
AT349020B (de) Verfahren zur herstellung neuer 3,4- dihydrocarbostyril-derivate und ihrer saeureadditonssalze
ATA342176A (de) Verfahren zur herstellung neuer 2-imidazolyl- chinazoline und ihrer salze
AT368993B (de) Verfahren zur herstellung neuer 4-hydroxy-2chinolinon-3-carbonsaeureester und ihrer pharmazeutisch vertraeglichen salze
AT377256B (de) Verfahren zur herstellung neuer 1-phenaethylimidazol-derivate und ihrer saeureadditionssalze
AT351020B (de) Verfahren zur herstellung neuer 4-phenyl- imidazoline und ihrer saeureadditionssalze
ATA67677A (de) Verfahren zur herstellung neuer 1-(2-phenyl-2- hydroxyaethylamino)-3-phenoxypropan-2-ole und ihrer saeureadditionssalze
AT347960B (de) Verfahren zur herstellung neuer hydrazinopyri- dazinderivate und deren salzen
AT348984B (de) Verfahren zur herstellung neuer omega- aminoalkoxyalkane und ihrer salze
ATA39976A (de) Verfahren zur herstellung neuer 2-6-bis- (aminoacylamino) -anthrachinone sowie ihrer saureadditionssalze
AT352713B (de) Verfahren zur herstellung neuer 1-azidoalkyl- imidazole und ihrer saeureadditionssalze
ATA269779A (de) Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze
ATA8579A (de) Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze
AT350519B (de) Verfahren zur herstellung von neuen omega- amino-alkoxycycloalkanen sowie deren saeure- additonssalzen
ATA799175A (de) Verfahren zur herstellung neuer thiazol-5-carbonsaurederivate und ihrer salze
ATA189379A (de) Verfahren zur herstellung neuer imidazol- derivate und ihrer salze

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties